Publications by authors named "R Baerg"

Claim this Profile
D
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease.
B R Yacyshyn, W Y Chey, J Goff, B Salzberg, R Baerg

Gut· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.
W J Sandborn, S B Hanauer, S Katz, M Safdi, D G Wolf, R D Baerg

Gastroenterology· November 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety.
N B Vakil, R Shaker, D A Johnson, T Kovacs, R D Baerg

Aliment Pharmacol Ther· July 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insecticide and Insecticide Metabolite Interactions with Cytochrome P450 Mediated Activities in Maize.
RJ Baerg, M Barrett, ND Polge

Pestic Biochem Physiol· May 1996

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of tourniquets on muscle enzymes during foot and ankle surgery.
R S Baerg

J Foot Ankle Surg· May 1994

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis